All Things Chromatography

We Work For Health honors Sen. Carper

U.S. Senator Tom Carper of Delaware was presented with this year’s Medical Innovation Champion award by the Dayton and EppesDelaware Chapter of We Work for Health (WWFH) at Junior Achievement of Delaware (JA) in Wilmington on August 27. The award was furnished in conjunction with a WWFH roundtable discussion on the future of medical innovation in Delaware.
 
Senator Carper’s work has been of tremendous importance to the robust medical innovation industry in Delaware, and the workforce and economic support it provides. He has been a strong supporter of the innovators, helping ensure they are able to recoup their investments with the protection of data exclusivity rights in health care reform. He is an advocate and supporter of the Delaware Health Information Network (DHIN) and Delaware becoming the first state to roll out electronic health records statewide.


“Senator Carper has gone to bat for innovators here in Delaware and around the country,” said Frank Howard, WWFH Campaign Manager. “His leadership in health care reform was critical in keeping important research alive.”
 
Medical innovation leaders in Delaware held a roundtable discussion following the award covering several issues of importance to the continued support of medical innovation in Delaware. Topics covered included narrowing gaps in translation research so more lab discoveries make it to market; navigating current limitations on private investment; reforming the Food and Drug Administration’s regulatory review process; and stimulating the cultivation of new innovators through Science, Technology, Engineering, and Mathematics (STEM) education and other programs.
 
“Today’s gathering allowed for important discussions on what steps we need to be taking to support future innovators,” said JA President and WWFH Delaware Chapter Co-Chair Rob Eppes. “Here at Junior Achievement, we are doing our part to prepare today’s students to be tomorrow’s leaders in medical innovation and research.”


Attendees were invited on a tour of JA’s Innovation Hub by Eppes. The Hub is a STEM career exploration zone within the JA World experiential learning center. Through virtual expeditions, students are able to explore local STEM career opportunities and the associated educational requirements. Preparations are underway for the Hub to host 2,700 students for the JA Innovation Hub Career and College Readiness Experience in late September.
 
Roundtable participants included representatives from: AIDS Delaware; Analtech, Inc.; Christiana Care Health System; Delaware AFL-CIO; Delaware Bioscience Association; Delaware Biotechnology Institute; Delaware Economic Development Office; Delaware Healthcare Commission; Delaware HIV Consortium; Delaware State University; Junior Achievement of Delaware; and Mid-Atlantic Association of Community Health Centers.
 
We Work for Health is a grassroots initiative that unites health consumers, biopharmaceutical company employees and retirees, vendors, suppliers and other business, academic and community partners to demonstrate how these diverse groups work together to improve America’s health care system and strengthen our economy.

Topics: Pharmaceutical Industry, BIO, Pharma, Pharma Industry

Notes from the Delaware BioScience Business Roundtable

The Biotechnology Industry Organization (BIO), National Venture Capital Association, Pharmaceutical Research and Manufacturers of America, U.S. Chamber of Commerce, Delaware BioScience Association, Delaware State Chamber of Commerce and Delaware HIV Consortium organized the Delaware BioScience Business Roundtable held at Christiana Care's John H. Ammon Medical Education Center on August 12.

This event brought together leaders from the bioscience, pharmaceutical, and chemical industries as well as top government officials.

The News Journal ran a great front page story on the event, here's an excerpt:

The life sciences already have a strong footprint in Delaware, thanks in part to the presence of industry giants such as chemical and biotech firm DuPont Co., drug maker AstraZeneca and Agilent. A study earlier this year by the University of Delaware's Center for Applied Demography & Survey Research found that the biopharmaceutical and related sectors employed nearly 12,000 people in Delaware in 2008.

Several speakers touted Delaware's advantages in the field of life sciences, including its strong sense of community, easy access to government officials and high concentration of Ph.D.s.

"We have a lot to build on," Gov. Jack Markell said in the event's keynote speech.

The complete article and photos from the event can be seen by clicking here.

In addition to the newspaper coverage, some of us were offering live twitter updates - here's a sample:

DEBioSci

Click Here to access the entire feed.

We were fortunate enough to catch up with some of the participants and get their insights on the BioScience Industry in Delaware, the U.S., and the world.

Gov. Jack Markell

Patrick Kelly, Vice President for State Government Relations and Alliance Development for the Biotechnology Industry Organization (BIO) based in Washington, DC

Catherine Bonuccelli, Global Product Vice President for Symbicort, AstraZeneca Pharmaceuticals LP

 

Topics: Delaware BioScience Association, biotechnology, Pharmaceutical Industry